Stockscreener 앱 받기
15.30
3.31%
0.49
시간 외 거래:
15.27
-0.03
-0.20%
Neuropace Inc 주식(NPCE)의 최신 뉴스
Orbimed Advisors LLC Decreases Holdings in NeuroPace, Inc. $NPCE - MarketBeat
Neuropace Inc (NPCE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
NeuroPace, Inc. $NPCE Shares Acquired by First Light Asset Management LLC - MarketBeat
NPCE|Neuropace Inc|Price:14.810|Chg%:+0.130 - TradingKey
Neuropace Inc (NPCE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Neuropace Inc (NPCE) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Neuropace Inc (NPCE) Valuation: PE, PB & Fair Value Analysis - TradingKey
NeuroPace Inc introduces real-time solution to help restore everyday independence - Traders Union
Neuropace Inc (NPCE) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Neuropace Inc (NPCE) Income Statement - TradingKey
NeuroPace Inc: Intermountain Health completes 100th RNS System implant for epilepsy patients - Traders Union
Neuropace Inc (NPCE) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Mizuho Securities Initiates NeuroPace(NPCE.US) With Buy Rating, Announces Target Price $22 - Moomoo
Mizuho Begins Coverage on NeuroPace (NASDAQ:NPCE) - MarketBeat
NEUROPACE INC : MIZUHO INITIATES COVERAGE WITH OUTPERFORM RATING; TARGET PRICE $22 - Bitget
Mizuho Securities Initiates Coverage on NeuroPace With Outperform Rating, $22 Price Target - marketscreener.com
Mizuho initiates NeuroPace stock coverage with outperform rating - Investing.com
NeuroPace Inc study reports landmark six month seizure reduction for RNS System patients - Traders Union
Neuropace, Inc. (NPCE) Q4 2024 Earnings ReportResults, Call & Slides - TipRanks
NeuroPace (NPCE) Proxy filing Summary - Quartr
(NPCE) Volatility Zones as Tactical Triggers - Stock Traders Daily
NeuroPace (NPCE) Stock Forum and Discussion - Moomoo
Here's why you should retain NeuroPace stock in your portfolio for now - MSN
NeuroPace (NPCE) 25th Annual Needham Virtual Healthcare Conference Summary - Quartr
Neuropace (NPCE) Holds Steady Near Resistance as Trading Volume Remains ModerateValue Area High - dars.gov.et
Here's Why You Should Retain NeuroPace Stock in Your Portfolio for Now - Yahoo Finance
NeuroPace (NASDAQ:NPCE) Shares Down 5.8%What's Next? - MarketBeat
NeuroPace, Inc. (NASDAQ:NPCE) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
NeuroPace (NASDAQ:NPCE) Stock Price Up 1.1%What's Next? - MarketBeat
NeuroPace Inc offers free webinar on RNS System for epilepsy patients - Traders Union
At US$17.80, Is It Time To Put NeuroPace, Inc. (NASDAQ:NPCE) On Your Watch List? - simplywall.st
DHR Health pioneers responsive neurostimulation therapy with NeuroPace Inc RNS System in Texas - Traders Union
Neuropace Inc. (NPCE) Q1 2026 Earnings: EPS Surpasses Estimates, Shares GainInvestor Earnings Call - dars.gov.et
Neuropace Inc. (NPCE) Q1 2026 Earnings: EPS Beats Estimates as Loss Narrows, Stock Rises 2.35%Trough Earnings Signal - dars.gov.et
Wall Street analysts see a 41.29% upside in NeuroPace (NPCE): Can the stock really move this high? - MSN
Price to earnings forward of Neuropace, Inc. – NASDAQ:NPCE - TradingView
NPCENeuroPace Inc Website Traffic and Mobile Apps Usage - Finviz
Neuropace Inc. (NPCE) Q1 2026 Earnings: Narrower-than-Expected Loss Lifts SharesBasic EPS Analysis - dars.gov.et
NeuroPace | 4: Statement of changes in beneficial ownership of securities-Director Fischer Frank M - Moomoo
NeuroPace Inc patients see 62 percent median seizure reduction at six months in largest FDA-reviewed study - Traders Union
Price-Driven Insight from (NPCE) for Rule-Based Strategy - Stock Traders Daily
FDA Approves NeuroPace AI Driven Feature For Epilepsy Care - HarianBasis.co
NeuroPace, Inc. (NPCE) Reveals FDA Approval of ECoG Assistant™ - Insider Monkey
NeuroPace, Inc. Actuals & Estimates (NASDAQ:NPCE) - TradingView
NeuroPace (NPCE) CMO has shares withheld to cover RSU tax bill - Stock Titan
NPCE Forecast — Price Target — Prediction for 2027 - TradingView
Neuropace Inc. (NPCE) Q1 2026 Earnings: Narrowed Loss Beats Estimates, Shares Edge HigherReturn On Assets - dars.gov.et
Neuropace Inc (NPCE) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Neuropace Inc. (NPCE) Gains on Rising Volume: Support Holds Above $15Fibonacci Extension - dars.gov.et
Form 4 Neuropace Inc For: 22 June By Investing.com - Investing.com Nigeria
[Form 4] NeuroPace Inc Insider Trading Activity - Stock Titan
NeuroPace (NPCE) director granted 789 shares as quarterly fee award - Stock Titan
NeuroPace | 4: Statement of changes in beneficial ownership of securities-Director Kumar Rakhi - Moomoo
NeuroPace (NPCE) director Rakhi Kumar awarded 989 shares as quarterly retainer - Stock Titan
0.79%
4.39%
자본화:
|
볼륨(24시간):